Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
12 February 2010
IN THIS ISSUE
PTE digital magazine
The industry's future
Biopharm products
Generics dominate EU
More...
cover
New to 2010: PTE launches new monthly digital magazine
In the first issue of PTE's monthly digital magazine, we discuss the trends and challenges of biopharmaceutical manufacture and highlight some of the key opportunities for companies working in this sector. More...
cover
Biopharmaceuticals: saving the future of our industry
Biopharmaceuticals are becoming increasingly prominent in the pharmaceutical industry and are expected to dominate product use and sales of the future. More...
cover
Biopharmaceutical product showcase
A range of some of the top biopharmaceutical technologies available on the European market. More...

EMA figures demonstrate generic dominance
Figures published by the European Medicines Agency (EMA) relating to centralized procedure activities for human medicines show a significant increase in the number of positive opinions made between 2007 and 2009; however, the majority of approvals are for generic products. More...

FDA strengthens import inspections
The FDA has unveiled a new program to improve the efficiency of import inspections. The Predictive Risk-Based Evaluation for Dynamic Import Compliance Targeting (PREDICT) information-technology system allows border inspectors to reliably monitor products at the port of entry and to focus inspections on shipments that pose the greatest risk. More...

Pfizer, Bayer and BMS advance personalized medicine products
Personalized medicine is still a nascent area for the pharmaceutical company, but several large pharmaceutical companies recently reported on developments in this area. More...

New unit for rare diseases R&D launched
GlaxoSmithKline (GSK) has launched a standalone unit that will specialize in the R&D and commercialization of medicines for rare diseases. More...

Product Profile
Center for Professional Advancement
  Access Training You Need Now

With over 100 Live and On-Demand Online Training courses, and nearly 300 instructor led courses to choose from - CfPA’s Accredited courses can ensure you receive the skills and knowledge that will make a difference in your career. Register now for: Suspensions & Emulsions for Pharma Amsterdam 8 March, GLP Amsterdam 10 March, or Combo Product Regulations 9 March Online

Event Profile
LogiPharma 2010
 


27-29 April
Intercontinental Hotel, Geneva


Today, more than ever before, supply chain managers must focus on cost-cutting, outsourcing logistics, improving customer service along the supply chain, improving supply chain agility, safety and visibility, all while remaining compliant with changing regulations. Read more...

Pharma Congress
  9-10 March 2010
Dusseldorf, Germany

The Pharma Congress Production & Technology has been Germany's leading convention in the pharma environment for 11 years, combining high-class special subject matter conferences, an adjacent exhibition and directly connected hotel accommodation. Read more...

Sanderson Weatherall
  Processing equipment auction and sale
Due to reorganisation of stock levels, a pharmaceutical manufacturer is offering stainless steel vessels and stock of unused engineering spares to the process industry for auction.

South Dublin City, Ireland
Bidding closes: 2pm Thursday 25 February 2010

Read more...

Podcast
Vetter Development Service Chicago
 


Peter Soelkner
Managing Director, Vetter Pharma International GmbH


Listen to this podcast recorded live from the show floor of AAPS 2009. Clinical development is key for new drugs. In order to minimize risks and take advantage of opportunities, you need comprehensive know-how and years of experience. Vetter, as a specialist in the aseptic filling of injection systems, will provide with its new facility the manufacturing of preclinical, Phase I and Phase II clinical batches in Chicago. We invite you to find out more about Vetter Development Services USA Inc.
Read more...

Key Topic Updates
Latest articles
Trends and challenges of biopharma manufacturing
Commercialising cellular therapies faster
Achieving site-specific PEGylation
More latest articles

Key Topic Updates


Survey
Recently, the following statement was made about lyophilisation: "To remove water by freezing it, subliming the ice and then condensing the water vapour is time consuming, wasteful in energy consumption and very expensive in hardware. An easier option is to evaporate (boil) the water." How far do you agree with this statement?
  Strongly agree 7%
  Agree 12%
  Neither agree nor disagree 11%
  Disagree 31%
  Strongly disagree 39%

This week we would like to know...

What factor do you think will be most significant in 2010 for determining the health of the market for contract manufacturing of APIs?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.comor by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.